The cost of targeted therapy in Ukraine typically ranges from $4,000 to $8,000. Pricing varies depending on the medication used (such as monoclonal antibodies or tyrosine kinase inhibitors), the number of treatment cycles, and the clinic’s expertise in oncology. In the United States, the average cost is $40,000 (per ASCO). This means targeted therapy in Ukraine is about 85% less expensive than in the U.S.
Ukrainian clinics usually include initial oncologist consultation, diagnostics, treatment planning, medication administration, and follow-up monitoring in the price. In the U.S., the quoted price often covers only the medication, with additional charges for consultations, lab tests, and supportive care. Always confirm which services and medications are included at your chosen clinic.
| Ukraine | Turkey | Austria | |
| Targeted therapy | from $4,000 | from $1,000 | from $12,000 |
| Lutetium-177 therapy | from $10,000 | from $6,500 | from $35,000 |
| Actinium-225 Therapy | from $18,000 | from $22,000 | from $55,000 |
Reviewed by Bookimed Medical Advisor
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
Written by Anna Shchur
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.